ATE433463T1 - Monospezifische antikörper gegen fibrinogen und fibrinopeptide b - Google Patents

Monospezifische antikörper gegen fibrinogen und fibrinopeptide b

Info

Publication number
ATE433463T1
ATE433463T1 AT98935874T AT98935874T ATE433463T1 AT E433463 T1 ATE433463 T1 AT E433463T1 AT 98935874 T AT98935874 T AT 98935874T AT 98935874 T AT98935874 T AT 98935874T AT E433463 T1 ATE433463 T1 AT E433463T1
Authority
AT
Austria
Prior art keywords
fpb
fibrinopeptide
provides
antibodies
monospecific
Prior art date
Application number
AT98935874T
Other languages
English (en)
Inventor
Bohdan Kudryk
Colvin Redman
Jian-Zhong Zhang
Original Assignee
New York Blood Ct Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Ct Inc filed Critical New York Blood Ct Inc
Application granted granted Critical
Publication of ATE433463T1 publication Critical patent/ATE433463T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/972—Modified antibody, e.g. hybrid, bifunctional
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98935874T 1997-07-25 1998-07-22 Monospezifische antikörper gegen fibrinogen und fibrinopeptide b ATE433463T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/900,660 US5876947A (en) 1997-07-25 1997-07-25 Monospecific antibody reactive with Fibrinogen and fibrinopeptide B
PCT/US1998/015059 WO1999005176A1 (en) 1997-07-25 1998-07-22 Monospecific antibody reactive with fibrinogen and fibrinopeptide b

Publications (1)

Publication Number Publication Date
ATE433463T1 true ATE433463T1 (de) 2009-06-15

Family

ID=25412892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98935874T ATE433463T1 (de) 1997-07-25 1998-07-22 Monospezifische antikörper gegen fibrinogen und fibrinopeptide b

Country Status (7)

Country Link
US (1) US5876947A (de)
EP (1) EP1007570B1 (de)
AT (1) ATE433463T1 (de)
AU (1) AU8503898A (de)
DE (1) DE69840895D1 (de)
ES (1) ES2328306T3 (de)
WO (1) WO1999005176A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040014158A1 (en) * 1999-03-08 2004-01-22 Adelbert Bacher Protein conjugates, methods, vectors, proteins and DNA for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates
DE19910102B4 (de) * 1999-03-08 2006-06-01 Fischer, Markus, Dr.rer.nat. Proteinkonjugate, Verfahren, Vektoren, Proteine und DNA zu deren Herstellung, deren Verwendung, sowie Arzneimittel und Impfstoffe mit einem Gehalt derselben
US6673561B1 (en) * 1999-06-30 2004-01-06 Regents Of The University Of California Diagnostic test for thrombotic or thromboembolic disease
CA2372700A1 (en) * 1999-06-30 2001-01-04 Regents Of The University Of California Diagnostic test for thrombotic or thromboembolic disease
US7828741B2 (en) * 2002-12-20 2010-11-09 The Charlotte-Mecklenburg Hospital Authority Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia
ATE427068T1 (de) * 2002-12-20 2009-04-15 Charlotte Mecklenburg Hospital Wegwerf-handvorrichtung zum auffangen von ausgeatmetem atemkondensat
US7547285B2 (en) * 2003-02-14 2009-06-16 The Charlotte-Mecklenburg Hospital Authority Device and method for collection of exhaled alveolar breath condensate
JP4695591B2 (ja) * 2003-06-18 2011-06-08 アポセンス リミテッド アポトーシス細胞を選択的に標的化する方法、および、それらに用いられる低分子物質リガンド
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
JP4968611B2 (ja) * 2006-12-29 2012-07-04 アボット・ラボラトリーズ 免疫抑制剤の改善された測定法
WO2009033680A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Galanin-like peptide alone or in combination with cyclo-argd as a therapeutic agent
US8900822B2 (en) 2011-11-21 2014-12-02 Ethicon, Inc. Fibrinogen assay

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68917797T2 (de) * 1988-06-10 1995-01-05 New York Blood Center Inc Gegen menschliches Fibrinopepid A spezifische monoklonale Antikörper.
JPH03287070A (ja) * 1990-04-03 1991-12-17 Tosoh Corp フィブリノペプタイドＢβ↓１‐↓４↓２の測定法

Also Published As

Publication number Publication date
EP1007570A4 (de) 2005-02-23
AU8503898A (en) 1999-02-16
ES2328306T3 (es) 2009-11-11
EP1007570B1 (de) 2009-06-10
DE69840895D1 (de) 2009-07-23
US5876947A (en) 1999-03-02
WO1999005176A1 (en) 1999-02-04
EP1007570A1 (de) 2000-06-14

Similar Documents

Publication Publication Date Title
CO4870792A1 (es) Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata
SE9500023D0 (sv) Method of detecting cancer
ATE426018T1 (de) Pca3, pca3-gene und verfahren zu ihrer verwendung
EP0175586A2 (de) Immunologisches Fluoreszenz-Polarisationsverfahren zum Nachweis von schweren Antigenen
DE69840895D1 (de) Monospezifische antikörper gegen fibrinogen und fibrinopeptide b
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
CA2192940A1 (en) Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
ATE196804T1 (de) Test für thrombosegefahr
CA2499926A1 (en) Antibody against von willebrand factor cleaving enzyme and assay system using the same
ATE462001T1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
JP2002542820A5 (de)
KR870008186A (ko) 면역글로부린 Al(IgAl) 단면 분석에 의한 임질진단방법, 그 시약 및 키트(kit)
Dardik et al. The structure of endothelial cell thrombospondin: Characterization of the heparin‐binding domains
KR960002740B1 (ko) 안티-트롬빈-결합물질 모노클로날 항체, 이를 생산하는 하이브리도마 및 모노클로날 항체를 이용한 트롬빈-결합물질의 정제법 및 측정법
Kaplan Proteins secreted by platelets: significance in detecting thrombosis
BR9815090A (pt) "moléculas de ácido nucléico correlacionadas com o fenótipo rhesus d fraco"
EP0655627B1 (de) Mittel zur direkten chemischen Bindung des D-Dimers aus einer biologischen Probe zwecks Diagnostik und Überwachung von thrombolytischen und hyperkoagulablen Zuständen
EP1852442B1 (de) Antikörper zur testung der adamts13-aktivität und diesbezügliche verfahren
ATE418604T1 (de) Gegen das prothrombin-fragment f1+2 gerichtete antikörper, ihre herstellung und verwendung
CN101074263B (zh) 一种重组抗proteinA单克隆抗体及其制备方法和用途
DE60334408D1 (de) Nsäuren
WO1991008488A1 (en) Trypsin inhibitor (alpha, at) peptide, immunoassay, monoclonal antibody and hybridoma
CA2399047A1 (en) Reagents and methods useful for detecting diseases of the breast
ATE158815T1 (de) Hippurikasegen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007570

Country of ref document: EP

REN Ceased due to non-payment of the annual fee